Browse

Latest Headlines

Fresh headlines, crisp visuals — faster reading.

Robotic Pet Therapy: A New Hope for Dementia Patients?

Robotic Pet Therapy: A New Hope for Dementia Patients?

A clinical trial at Sarasota Memorial Health Care System explored the effects of robotic pet therapy on seniors with mild to moderate dementia. The year-long study aimed to evaluate emotional and behavioral outcomes from this non-pharmacological approach. Overview of the Robotic Pet Therapy Study Led by Joanna D’Elia, MSN, RN, GERO-BC, CPHQ, the study was one of the first to use robotic pets in a hospital setting. The lifelike pets are interactive cats and dogs designed to comfort patients. Upon hospital admission, patients chose a robotic pet that they could later take home. The study included older adults with dementia and divided them into two groups: one received robotic pets during their stay, while the other received standard care. Results showed improved vital signs and reduced hospital stays for those with companion pets. The trial was funded by Deb Kabinoff, emphasizing her interest in innovative technologies that soothe dementia patients. Patients with companion pets had better discharge outcomes, returning home more often than moving to long-term care facilities. The Benefit of Lifestyle Intervention Therapies Conducting hospital-based trials in community settings reduces participation barriers for underrepresented groups and encourages involvement without disrupting daily routines. Such non-pharmacological treatments help manage conditions like dementia without medication side effects. This approach parallels studies on cardiovascular health integrating lifestyle adjustments, providing similar accessibility benefits. Dementia in the Black Community Five point eight million Americans live with Alzheimer’s or related dementias, with African Americans disproportionately affected. They often face later diagnoses and greater challenges due to socioeconomic factors impacting healthcare access. Black communities are generally underrepresented in clinical trials for conditions like heart disease and dementia. Initiatives like the SMH trial aim to bridge this gap by integrating culturally relevant research methods into familiar healthcare environments, promoting trust and participation among underserved populations.

Mar 12, 2026
Dark Joseph Ravine's Big Moves: Speaks, Donates, and Shares at "The Hope Tour"

Dark Joseph Ravine's Big Moves: Speaks, Donates, and Shares at "The Hope Tour"

Dark Joseph Ravine, a Canadian entrepreneur, participated in Canada's "The Hope Tour" event on February 26, 2026. Through his company Focus Five Group, he donated marketing services to the initiative to emphasize using influence for helping others. A Marketing Agency's Contribution The event attracted around 200 attendees with discussions on utilizing skills and influence for community betterment. Ravine highlighted that Focus Five Group supports initiatives through strategic marketing, promoting engagement and long-term impact. Ravine stressed the importance of influence paired with responsibility, stating: "This life is not about you; it’s about helping as many people as you can." His approach focuses on service rather than prestige. Interviews and Insights Ravine conducted interviews with figures like Alicia Vianga and Jonathan Harvey, discussing leadership and tangible contributions. The conversations emphasized that real influence comes through time, talent, or resources. "Everyday Heroes" During his speech, Ravine inspired attendees to become everyday heroes by making meaningful contributions. He urged those in power to use platforms wisely and promote genuine commitment to service. He concluded by emphasizing the need for passion to make a difference, saying: “If you don’t have passion, you don’t get nowhere.” The Bigger Picture As economic pressures mount in Canada, The Hope Tour encourages aligning business efforts with community improvement. Ravine proposed that focus should be on impact first and recognition second. The involvement of Focus Five Group in such initiatives reflects a shift towards accountability and civic engagement. Ravine believes success is defined by how many people you help along the way.

Mar 12, 2026
Breaking Down Barriers to Clinical Trials for Black Americans

Breaking Down Barriers to Clinical Trials for Black Americans

Clinical trials are essential for advancing cancer treatment, particularly for Black Americans who face higher mortality rates and healthcare inequities. Understanding the barriers to clinical trial participation among Black patients in the U.S. is crucial for improving representation. A survey conducted with the Association of Community Care Centers, the Oncology Research Institute, and the American Society of Clinical Oncology explored these barriers and strategies to overcome them. Barriers to Clinical Trial Participation for Black Americans The survey identified key factors affecting enrollment in clinical trials, suggesting improvements aligned with FDA guidance to increase minority group participation. Key barriers include wavering patient participation due to lack of communication, cultural concerns, and financial issues. It emphasized the need for better infrastructure at community care sites where staffing limitations hinder clinical research efforts. Additionally, geographical disparities affect trial availability, suggesting expansion into rural and suburban areas could improve access. How Do Clinical Trials Benefit the Medical Field? Clinical trials offer healthcare professionals vital insights into patient care and potential new treatments. These trials not only enhance current medical knowledge but also provide patients with access to treatments that may not be available through standard care. How Do Clinical Trials Benefit Black Americans with Cancer? For Black cancer patients, participating in clinical trials helps not only in their treatment but also in developing treatments that could benefit others facing similar conditions. Historically, inconsistencies in trial design have led to misalignments with the specific needs of Black patients. To ensure equitable medical access, clinical trials must represent those affected by specific conditions. More participation from Black cancer patients provides valuable data on how best to address their unique healthcare needs. To learn more about clinical trials, visit our Clinical Trials Resource Center.

Mar 12, 2026
Drooling in Your Sleep? It Could Signal Something Serious!

Drooling in Your Sleep? It Could Signal Something Serious!

Many people experience drooling during sleep, but excessive drooling could indicate a health issue. Occasional drooling is common, but frequent episodes may suggest conditions like sleep disorders or neurological problems. Why People Drool in Their Sleep Drooling occurs when saliva escapes the mouth during sleep. Causes include side or stomach sleeping, relaxed facial muscles, and mouth breathing due to nasal congestion. Dr. Abhinav Singh notes that while occasional drooling is normal, frequent occurrences should be examined further. Serious Health Conditions Linked to Sleep Drooling Persistent drooling can be a symptom of various health issues. Obstructive sleep apnea, for instance, causes mouth breathing and swallowing difficulties, increasing drooling risk. Other conditions include GERD, which prompts excess saliva production; neurological disorders like Parkinson’s disease; sinus infections; allergies; medication side effects; and oral muscle disorders. When Should You Be Concerned? If drooling is frequent or severe, it may require medical attention. Symptoms such as choking, snoring, difficulty swallowing, or neurological changes suggest an underlying condition needing evaluation through tests like sleep studies or neurological assessments. How to Combat Drooling During Sleep Strategies to reduce drooling include adjusting sleep positions to back sleeping, addressing nasal congestion with treatments like antihistamines and nasal sprays, and using dental devices to keep the mouth closed. Strengthening oral muscles through exercises and pursuing medical treatments can also help manage persistent cases.

Mar 12, 2026
Sonja Norwood Breaks Silence on Kardashian-Jenner Tape Allegations

Sonja Norwood Breaks Silence on Kardashian-Jenner Tape Allegations

Sonja Norwood is supporting her son Ray J in his legal struggle with the Kardashian-Jenner family over a controversial intimate tape. Kim Kardashian and Kris Jenner denied under oath Ray J's claims about the tape's release being orchestrated. Legal Battle Overview Kim and Kris sued Ray J for defamation, countering his long-standing allegations about plotting the tape's release. He responded with a countersuit seeking damages, alleging they violated a previous settlement agreement that forbade discussing the tape. The lawsuit unveiled accusations from both sides, with Kris labeling Ray J’s statements as lies and him accusing them of commercial exploitation. Court Testimonies Under oath, Kim stated that any claims of her and her mother's involvement in releasing the tape were false. Similarly, Kris dismissed accusations of making Kim film the video or deciding on its release as untruthful. Kris also accused Ray J of "publicly terrorizing" Kim for years, while Kim expressed concerns that this could affect her career aspirations. Sonja Norwood's Response Sonja Norwood took to Instagram to defend her son, expressing belief in his version of events. She questioned Kris Jenner’s statements and affirmed support for Ray J’s pursuit of truth regarding the tape controversy. "I support @rayj and his journey to bring the truth forward," she wrote. Sonja challenged Kris’s denial of orchestrating the tape's release, asking directly who was responsible if not her.

Mar 12, 2026